Last updated on May 2019

Efficacy and Systemic Safety of Netarsudil 0.01% 0.02% 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan


Brief description of study

Test ocular hypotensive efficacy and systemic safety of netarsudil 0.01%, 0.02%, 0.04% relative to placebo in subjects with open-angle glaucoma or ocular hypertension in Japan

Clinical Study Identifier: NCT03844945

Find a site near you

Start Over

Tamagawa Eye Clinic

Ota-ku, Japan
0.01miles
  Connect »

Hashida Eye Clinic

Shinagawa-Ku, Japan
3.41miles
  Connect »

Watanabe Eye Clinic

Shinagawa-Ku, Japan
3.41miles
  Connect »

Seijo Clinic

Setagaya-Ku, Japan
6.87miles
  Connect »

Dogenzaka Kato Eye Clinic

Shibuya-ku, Japan
6.99miles
  Connect »

Wakabadai Eye Clinic

Shibuya-ku, Japan
6.99miles
  Connect »

Ochanomizu Inoue Eye Clinic

Chiyoda-ku, Japan
9.42miles
  Connect »

Kiyosawa Eye Clinic

Koto-Ku, Japan
9.58miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.